Senate Minority Leader Charles E. Schumer (D-N.Y.) recommended May 9 that President Donald Trump tap consumer advocate Rohit Chopra to serve as a member of the Federal Trade Commission.
Chopra is a senior fellow at Consumer Federation of America and previously worked at the Department of Education and the Consumer Financial Protection Bureau.
Schumer’s initiative may prompt the Trump Administration to bring the commission up to full strength.
Republican Maureen K. Ohlhausen and Democrat Terrell McSweeny are the present FTC commissioners. President Trump Jan. 25 selected Ohlhausen to be the commission’s acting chairman. Schumer may get a chance to recommend another Democrat for FTC commissioner, as McSweeny’s term expires in September.
“Traditionally the Senate defers to the opposition’s party selection for an FTC commissioner,” D. Reed Freeman, a partner at Wilmer Cutler Pickering Hale and Dorr LLP in Washington and co-chair of the firm’s cybersecurity, privacy and communications practice, told Bloomberg BNA May 9.
If Trump accepts Schumer’s recommendation and Chopra is confirmed by the Senate, he would join a small group of FTC commissioners who aren’t attorneys. The last commissioner who wasn’t an attorney was Orson Swindle, who served on the commission until June 2005. The last non-attorney chairman was Janet D. Steiger, who left the commission in September 1997.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas